Fixkoh Airmaster is available in three strengths, providing pre-metered salmeterol/fluticasone doses of 50/100 microgram, 50/250 microgram and 50/500 microgram.
Further informationView Fixkoh Airmaster drug record
Like Seretide Accuhaler, Fixkoh Airmaster is licensed for the regular treatment of asthma where a long-acting β2-agonist (LABA) and inhaled corticosteroid (ICS) is appropriate; and for the symptomatic treatment of COPD in patients with a pre-bronchodilator FEV1 <60% predicted and a history of exacerbations who have significant symptoms despite regular bronchodilator therapy. It is suitable for patients from the age of 12 years.
The breath-actuated Airmaster device is primed by pressing the red button to slide open the mouthpiece cover until it clicks.
To compare Fixkoh Airmaster with existing LABA/ICS inhalers, prescribers can consult the MIMS comparison tables for asthma and COPD preparations, asthma combination inhalers, COPD combination inhalers, and breath-actuated inhalers. Images of the three strengths can be found in the MIMS visual guide to respiratory devices.